NCT04098991View on ClinicalTrials.gov

Improving White Matter Integrity With Thyroid Hormone

CompletedOBSERVATIONAL
Enrollment

5

Participants

Timeline

Start Date

November 8, 2017

Primary Completion Date

November 8, 2019

Study Completion Date

November 8, 2019

Conditions
Hypothyroidism
Interventions
DRUG

Levothyroxine

All participants will be treated for their hypothyroidism according to the standard of care as reflected in recent guidelines from the American Thyroid Association.

Trial Locations (1)

60612

University of Illinois at Chicago, Chicago

All Listed Sponsors
collaborator

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

lead

University of Illinois at Chicago

OTHER

NCT04098991 - Improving White Matter Integrity With Thyroid Hormone | Biotech Hunter | Biotech Hunter